NDC and Billing Codes for KEYTRUDA QLEX
Melanoma: Advanced and Adjuvant Settings
NSCLC: Advanced, Adjuvant, and Neoadjuvant Followed by Adjuvant Settings
Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma
Locally Advanced and Metastatic or Unresectable, Recurrent HNSCC
Advanced Urothelial Cancer
Cisplatin-Ineligible Muscle Invasive Bladder Cancer
High-Risk Non-Muscle Invasive Bladder Cancer
Advanced MSI-H/dMMR Cancers
Advanced MSI-H/dMMR CRC
Advanced Gastric or GEJ Adenocarcinoma
Advanced Esophageal or GEJ Carcinoma
Advanced Cervical Cancer
Hepatocellular Carcinoma
Advanced Biliary Tract Cancer
Advanced Merkel Cell Carcinoma
RCC: Advanced and Adjuvant Settings
Endometrial Carcinoma
Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) or Locally Advanced cSCC
High-Risk Early-Stage TNBC and Advanced TNBC
Platinum-Resistant Ovarian Cancer
Selected Safety Information for KEYTRUDA